Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.30
    OpenPayerBilling CodesDiseases and Disorders of the Digestive SystemDRG 332-rectal-resection-with-mcc
    Ask Trek AI about this page

    Rectal Resection with MCC: Inpatient Reimbursement Overview

    DRG 332 encompasses rectal resection cases with a Major Complication or Comorbidity, reflecting increased clinical complexity and resource needs. This matters for inpatient reimbursement because the presence of a Major Complication or Comorbidity shifts payment to a higher-weighted Diagnosis-Related Group to compensate for greater costs of care.

    Customize your policy alerts

    Sign up for drg 332 policy alerts

    Get alerted when payer policies referencing 332 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 332 Overview

    DRG 332 covers inpatient admissions for rectal resection procedures when a Major Complication or Comorbidity is present, indicating higher clinical complexity. Typical cases include resections for malignancy, complicated inflammatory disease, or ischemia with significant physiologic derangement. This Diagnosis-Related Group carries higher payment relative to less severe categories to account for increased resource use, longer lengths of stay, and more intensive post-operative care. Accurate coding of diagnoses and procedures is critical to align reimbursement with the clinical severity documented.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Perioperative enhanced recovery and complication reduction trials: randomized or pragmatic studies evaluating enhanced recovery after surgery (ERAS) protocols, perioperative antibiotic timing/duration, and surgical site infection prevention strategies for adults undergoing rectal resection with major complications (eg, anastomotic leak, sepsis). These studies enroll high-risk surgical patients (often elderly, with comorbidities or neoadjuvant therapy exposure) to test perioperative bundles and early detection algorithms; results inform protocols that can reduce ICU stays and readmissions. Findings are directly relevant to hospitals and payers because reducing immediate postoperative complications and length of stay lowers costs and resource utilization for this high-cost DRG.
    • Comparative effectiveness trials of surgical techniques and reconstructive approaches: head-to-head studies comparing open, laparoscopic, and minimally invasive/robotic rectal resections as well as sphincter-sparing versus more radical resections in patients with complex rectal pathology and significant complications. These trials focus on operative morbidity, rates of reoperation, short-term functional outcomes, and need for permanent or temporary ostomy in patients with advanced disease or adverse intraoperative events; they help determine which approaches yield lower complication burdens. Payers and surgical programs use this evidence to guide procedure selection, credentialing, and expected resource allocation for cases that fall into DRG 332.
    • Post-discharge outcomes and care transitions research: prospective cohort and interventional studies addressing post-acute management, including early outpatient follow-up, home health/nursing utilization, wound and ostomy care programs, and readmission prevention for patients discharged after rectal resection complicated by major conditions. These studies target patients at high risk of readmission or durable disability and measure patient-reported outcomes, unplanned healthcare use, and long-term functional status over months to a year; they identify economical care pathways and thresholds for post-acute services. Results are important to payers and health systems in managing total episode costs, bundle payments, and quality metrics tied to this DRG.

    Related Codes

    326-STOMACH-ESOPHAGEAL-AND-DUODENAL-PROCEDURES-WITH-MCC

    Stomach, Esophageal and Duodenal Procedures with MCC: Inpatient Reimbursement Overview

    327-STOMACH-ESOPHAGEAL-AND-DUODENAL-PROCEDURES-WITH-CC

    Stomach, Esophageal and Duodenal Procedures with CC: Inpatient Reimbursement Overview

    328-STOMACH-ESOPHAGEAL-AND-DUODENAL-PROCEDURES-WITHOUT-CC-MCC

    Stomach, Esophageal and Duodenal Procedures without CC/MCC: Inpatient Reimbursement Overview

    329-MAJOR-SMALL-AND-LARGE-BOWEL-PROCEDURES-WITH-MCC

    Major Small and Large Bowel Procedures with MCC: Inpatient Reimbursement Overview

    330-MAJOR-SMALL-AND-LARGE-BOWEL-PROCEDURES-WITH-CC

    Major Small and Large Bowel Procedures with CC: Inpatient Reimbursement Overview

    331-MAJOR-SMALL-AND-LARGE-BOWEL-PROCEDURES-WITHOUT-CC-MCC

    Major Small and Large Bowel Procedures without CC/MCC: Inpatient Reimbursement Overview

    333-RECTAL-RESECTION-WITH-CC

    Rectal Resection with CC: Inpatient Reimbursement Overview

    334-RECTAL-RESECTION-WITHOUT-CC-MCC

    Rectal Resection without CC/MCC: Inpatient Reimbursement Overview

    335-PERITONEAL-ADHESIOLYSIS-WITH-MCC

    Peritoneal Adhesiolysis with MCC: Inpatient Reimbursement Overview

    336-PERITONEAL-ADHESIOLYSIS-WITH-CC

    Peritoneal Adhesiolysis with CC: Inpatient Reimbursement Overview

    Showing 1–10 of 57

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.